Fidelity Disruptive Medicine ETF Rating → Radical change coming — do this NOW to protect yourself (From Weiss Ratings) (Ad) Free FMED Stock Alerts $23.63 -0.22 (-0.92%) (As of 02:22 PM ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsTrendsStock AnalysisChartHoldingsOwnershipRatingsTrends Fidelity Disruptive Medicine ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FMED Aggregate RatingModerate Buy2.75Holdings in FMED have an aggregate rating of Moderate Buy based on 644 analyst ratings issued in the past year covering 46 companies (90.5% of the portfolio).FMED Aggregate Price Target$29.9726.83% UpsideHigh Prediction$38.39Average Prediction$29.97Low Prediction$22.54Holdings in FMED have an aggregate price target of $29.97 and a range of $22.54 to $38.39 covering 46 companies (90.5% of the portfolio).FMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy38 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Fidelity Disruptive Medicine ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 46 FMED Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.65%BSXBoston Scientific$76.42-0.4%4 of 5 stars2.95$76.70 0.4%22Analyst DowngradeShort Interest ↑4.19%UNHUnitedHealth Group$490.26-1.0%5 of 5 stars2.95$579.74 18.3%203.86%DHRDanaher$254.59-0.1%4 of 5 stars2.67$269.29 5.8%15Short Interest ↑Positive News3.75%ISRGIntuitive Surgical$431.51+1.3%4 of 5 stars2.78$403.67 -6.5%18Short Interest ↑3.46%PODDInsulet$199.26-0.6%5 of 5 stars2.83$239.18 20.0%18Short Interest ↓3.35%ALNYAlnylam Pharmaceuticals$157.67-1.7%5 of 5 stars2.59$216.19 37.1%17Options VolumePositive News3.31%CNCCentene$68.14-1.1%5 of 5 stars2.43$84.93 24.6%14Short Interest ↑2.67%REGNRegeneron Pharmaceuticals$1,049.25+1.2%4 of 5 stars2.76$991.18 -5.5%22Analyst Forecast2.65%SYKStryker$344.900.0%5 of 5 stars2.79$370.58 7.4%19Positive News2.58%LLYEli Lilly and Company$887.41+1.0%4 of 5 stars2.84$787.53 -11.3%19Gap Up2.49%MRKMerck & Co., Inc.$127.60-0.9%4 of 5 stars2.69$133.00 4.2%13Options Volume2.38%LEGNLegend Biotech$42.17-0.7%2 of 5 stars3.00$80.21 90.2%12Analyst ForecastGap Up2.31%PENPenumbra$187.83+0.0%4 of 5 stars2.70$300.64 60.1%10Gap Up2.24%ARGXargenx$380.54-1.7%3 of 5 stars2.80$520.68 36.8%20Analyst ForecastPositive News2.23%EWEdwards Lifesciences$86.90-0.4%5 of 5 stars2.65$95.06 9.4%20Positive NewsGap Down2.16%TMOThermo Fisher Scientific$567.00-0.9%5 of 5 stars2.72$607.94 7.2%18Ex-DividendPositive News2.04%RPRXRoyalty Pharma$26.53-1.4%5 of 5 stars2.80$43.00 62.1%5Positive News1.92%VEEVVeeva Systems$180.54-2.3%5 of 5 stars2.60$227.95 26.3%20Analyst ForecastPositive News1.92%GKOSGlaukos$111.68-0.8%3 of 5 stars2.82$112.27 0.5%11Gap Up1.92%LFSTLifeStance Health Group$5.29+0.2%2 of 5 stars2.20$8.80 66.4%51.91%TECHBio-Techne$74.89-1.3%4 of 5 stars2.73$81.00 8.2%11Positive News1.90%INSPInspire Medical Systems$165.72-0.6%5 of 5 stars2.69$253.87 53.2%16Short Interest ↑Positive News1.79%EXASExact Sciences$41.60-0.7%4 of 5 stars2.92$93.07 123.7%131.68%DXCMDexCom$117.77+1.6%5 of 5 stars2.87$140.94 19.7%15Options Volume1.68%MASIMasimo$136.12+0.3%4 of 5 stars2.57$143.57 5.5%71.56%RGENRepligen$123.88-1.4%5 of 5 stars2.89$197.75 59.6%9Insider BuyingPositive News1.43%RMDResMed$211.00-0.3%5 of 5 stars2.70$202.80 -3.9%10Positive News1.37%HUMHumana$355.15-1.1%5 of 5 stars2.43$423.63 19.3%211.33%PCVXVaxcyte$72.58-0.5%0 of 5 stars3.00$78.50 8.2%4Positive News1.23%CYTKCytokinetics$53.56-0.7%4 of 5 stars2.82$76.41 42.7%17Analyst ForecastShort Interest ↑Positive News1.18%SRPTSarepta Therapeutics$118.49-3.5%5 of 5 stars2.80$164.00 38.4%15Analyst ForecastPositive News1.16%XENEXenon Pharmaceuticals$36.83-1.1%2 of 5 stars3.00$59.11 60.5%9Positive News1.16%JANXJanux Therapeutics$40.90-2.6%3 of 5 stars2.88$66.29 62.1%8Positive News1.12%PRVAPrivia Health Group$17.33-0.8%4 of 5 stars2.93$24.92 43.8%14Positive News1.09%AGLagilon health$6.59-4.5%1 of 5 stars2.16$9.03 37.1%191.08%VRTXVertex Pharmaceuticals$476.87-0.8%4 of 5 stars2.50$438.48 -8.1%24Analyst Upgrade1.07%TNDMTandem Diabetes Care$43.49-4.1%4 of 5 stars2.92$51.25 17.8%13Positive News1.06%BRKRBruker$65.08+0.9%5 of 5 stars2.56$85.00 30.6%9Positive News1.05%WSTWest Pharmaceutical Services$338.35+1.5%5 of 5 stars2.75$442.75 30.9%4Positive News1.00%ASNDAscendis Pharma A/S$124.83-2.2%3 of 5 stars2.89$179.44 43.8%9Positive News0.99%TXG10x Genomics$19.88-1.8%5 of 5 stars2.54$46.62 134.5%13Positive News0.98%PHRPhreesia$19.70+0.9%5 of 5 stars2.86$30.92 57.0%14Gap Up0.98%EVHEvolent Health$21.77+0.5%2 of 5 stars2.92$42.00 92.9%12Positive News0.96%NTRANatera$111.71+1.4%2 of 5 stars3.00$101.19 -9.4%16Positive News0.92%ALGNAlign Technology$247.95-3.1%5 of 5 stars2.50$351.00 41.6%10Positive NewsGap Up0.74%GHGuardant Health$30.68+1.6%5 of 5 stars2.86$36.91 20.3%14Short Interest ↓Positive News This page (NASDAQ:FMED) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
